RetinAI
Healthcare Software · Switzerland · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Freiburgstrasse 3, Bern, Bern, 3010, Swi...Phone Number
+33 629395525Website
www.retinai.comRevenue
$9.7 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
2
1
1
About RetinAI
RetinAI operates as a healthcare technology company specializing in artificial intelligence-driven software solutions for ophthalmology. Headquartered in Switzerland with additional presence in the United States and Europe, the organization focuses on transforming how eye-related medical data is collected, analyzed, and utilized across clinical care, research, and pharmaceutical development. The company has established itself at the intersection of healthcare, data science, and machine learning by developing platforms that enable more efficient and informed decision-making in the diagnosis and management of eye diseases. The company’s core offering centers around its proprietary platform, Discovery, which serves as a comprehensive data management and analytics system for ophthalmic imaging and clinical data. This platform aggregates and harmonizes data from multiple sources, including optical coherence tomography scans, fundus images, electronic health records, and other medical dataseRead more
RetinAI Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is RetinAI your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if RetinAI had a recent Job posting/layoffs
RetinAI, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if RetinAI is spiking on competitors!
Earning: See what the market has to say on RetinAI recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when RetinAI launches new products
Check if RetinAI has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once RetinAI has new funding data
Congratulate Masked Content for being promoted to Masked Content at RetinAI
Website visits: Recent activity has been detected on your website
Recommended Actions
Find VP level buyers at RetinAI
Find more new buyers
Company Profile Activity
Activity Insights
RetinAI is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
RetinAI is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about RetinAI.
RetinAI financials insights
Gather financial insights about RetinAI, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Series B
$8M
RetinAI Tech Stack
A closer look at the technologies used by RetinAI
Most Recent Scoops
Open Position
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
Open Position
Hiring Plans
RetinAI has more open roles in Engineering & Technical than it has had at any time in the past 12 months. Technologies mentioned include: Amazon AWS, Logstash, Ruby on Rails, Python, GitLab, and R.
Hiring Plans
Hiring Plans
Hiring Plans
RetinAI News & Media
EssilorLuxottica acquires RetinAI, accelerating transformative AI and data-powered eye health solutions
EssilorLuxottica acquires RetinAI, accelerating transformative AI and data-powered eye health solutionsEthan Yan Featured in XYZ Media’s 'Next Generation of Innovators' for RetinAI, an AI-Powered System Making Early Eye Cancer Detection Affordable and Accessible
LOS ANGELES, June 05, 2025 (GLOBE NEWSWIRE) -- XYZ Media, a leading media company that bridges educational pursuits with technological innovation, is thrilled to announce a new season of its “Next Generation of Innovators” series, a digital campaign that casts a spotlight on the extraordinary young leaders shaping the future through inventive solutions to global challenges. This series proudly features Ethan Yan, a Groton School student whose innovation, RetinAI, significantly advances the earlyRetinAI and FVS Announce CE-MDR Certification for Co-developed AI-based Diabetic Retinopathy Screening Algorithm, LuxIA®
BERN, Switzerland and MADRID, April 30, 2025 (GLOBE NEWSWIRE) -- RetinAI US Inc. (RetinAI) and Fundación Ver Salud (FVS) are pleased to jointly announce that LuxIA®, their co-developed innovative AI algorithm for Diabetic Retinopathy (DR) screening, has successfully received CE-MDR certification as a Class IIb medical device under the European Union Medical Device Regulation (EU MDR 2017/745). The certification was granted through Ikerian AG, RetinAI’s parent company.Ikerian announces commercial expansion of RetinAI Discovery in Europe
New investment from Sanoptis will support Ikerian technology for large-scale, AI-enabled data management
Read more news
Top Healthcare Software Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding RetinAI
Sign Up For FreeTo access detailed company insights
RetinAI operates as a healthcare technology company specializing in artificial intelligence-driven software solutions for ophthalmology. Headquartered in Switzerland with additional presence in the United States and Europe, the organization focuses on transforming how eye-related medical data is collected, analyzed, and utilized across clinical car... Read More
